MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 194 filers reported holding MYRIAD GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $534,818 | -54.5% | 21,865 | -64.4% | 0.00% | -60.0% |
| Q4 2023 | $1,174,373 | -46.3% | 61,357 | -55.0% | 0.01% | -54.5% |
| Q3 2023 | $2,185,835 | -21.2% | 136,274 | +13.9% | 0.01% | -21.4% |
| Q2 2023 | $2,774,298 | +97.6% | 119,685 | +98.0% | 0.01% | +75.0% |
| Q1 2023 | $1,404,091 | +776.9% | 60,443 | +447.7% | 0.01% | +700.0% |
| Q4 2022 | $160,118 | -81.8% | 11,035 | -75.2% | 0.00% | -80.0% |
| Q4 2020 | $879,000 | -20.2% | 44,442 | -47.4% | 0.01% | -28.6% |
| Q3 2020 | $1,101,000 | +38.0% | 84,464 | +207.5% | 0.01% | +40.0% |
| Q4 2018 | $798,000 | -72.8% | 27,466 | -56.9% | 0.01% | -70.6% |
| Q3 2018 | $2,930,000 | +78.5% | 63,691 | +45.0% | 0.02% | +88.9% |
| Q2 2018 | $1,641,000 | +261.5% | 43,925 | +186.2% | 0.01% | +200.0% |
| Q1 2018 | $454,000 | -70.0% | 15,350 | -61.7% | 0.00% | -72.7% |
| Q1 2014 | $1,513,000 | – | 40,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tieton Capital Management, LLC | 122,428 | $3,618,000 | 3.32% |
| Sensato Investors LLC | 553,505 | $16,356,000 | 2.54% |
| Camber Capital Management LP | 1,500,000 | $44,325,000 | 2.18% |
| S&T BANK/PA | 387,084 | $11,439,000 | 2.04% |
| Taylor Frigon Capital Management LLC | 46,989 | $1,389,000 | 1.08% |
| AIMZ Investment Advisors, LLC | 43,785 | $1,294,000 | 0.94% |
| Matarin Capital Management, LLC | 398,828 | $11,785,367,000 | 0.88% |
| Summit Street Capital Management, LLC | 30,097 | $889,000 | 0.88% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,321,171 | $39,041,000 | 0.77% |
| Millrace Asset Group, Inc. | 45,544 | $1,346,000 | 0.65% |